mr J BRENNAN

Implementation of the Affordable Care Act of 2010 (Pub. L. 111-148) Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) Pub.L. 112-144) H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 H.R. 3742, Antibiotic Development to Advance Patient Treatment (ADAPT) Act H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act

Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25); S.1284, FY 2015 Labor, HHS and Education Appropriations; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs. Implementation of the Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). FDA regulation of medical devices.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 Regulation of innovative biological products for neurodegenerative diseases.

Medicare Part B payment for drugs.

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). FDA regulation of medical devices.

Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25); S.1284, FY 2015 Labor, HHS and Education Appropriations; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part B payment for drugs.

Medicare payment and coding for clinical laboratory tests; H.R. 4302: Protecting Access to Medicare Act of 2014, P.L. 113-93.

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). FDA regulation of medical devices.

Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25); S.1284, FY 2015 Labor, HHS and Education Appropriations; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs.

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part B payment for drugs.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

Medicare Part B payment for drugs.

Medicare Part B payment for drugs.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8

Medicare Part B payment for drugs.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

MODDERN Cures Act, H.R. 3091 and H.R. 3116.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

Issues related to OTC drug products; issues related to pseudoephedrine; issues related to the regulation of cosmetic products

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

MODDERN Cures Act, H.R. 3091 and H.R. 3116.

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage and reimbursement of novel therapeutics for the treatment of obesity.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).

Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25); S.1284, FY 2014 Labor, HHS and Education Appropriations; Hepatitis C Policy; Hepatitis C issues; Hepatitis Funding for Screening and Linkage to Care Programs.

Medicare Part B payment for drugs.

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the coverage in reimbursement of novel therapeutics for the treatment of obesity.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding Americas Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

Issues related to OTC drug products; issues related to pseudoephedrine; issues related to the regulation of cosmetic products

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

H.R. 3497, the MODDERN Cures Act.

Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144) S. 957, Drug Supply Chain Security Act; H.R. 1919 the Safeguarding America's Pharmaceuticals Act of 2013 S. 959, Pharmaceutical Compounding Quality and Accountability Act

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of Orphan Drug Act and orphan drug development.

Healthcare regulatory issues; comparative effectiveness research in healthcare; healthcare reimbursement issues; medical research issues; science, technology, and R&D policy issues Issues related to FDA medical device safety

Healthcare regulatory issues; comparative effectiveness research in healthcare; healthcare reimbursement issues; medical research issues; science, technology, and R&D policy issues Issues related to FDA medical device safety

FY14 Labor and Health and Human Services Appropriations bill; promotion of 2007 NIH Expert Panel Guidelines for the Diagnosis and Management of Asthma.

Domestic HIV Policy Issues; Hepatitis B Funding for Screening and Linkage to Care Programs; Budget Control Act of 2011(P.L. 112-25)

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8

Implementation of Orphan Drug Act and orphan drug development.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011.

Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiations, and implementation of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB")

Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) The American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8

Medicare Reimbursement regarding SGR and ASC payments.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.

S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

S.3187, Food and Drug Administration Safety and Innovation Act.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).

Medicare Reimbursement regarding SGR and ASC payments.

Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

H.R. 3497, the MODDERN Cures Act.

S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.

Medicare drug reimbursement

Medicare drug reimbursement.

Medicare drug reimbursement.

Congressional outreach regarding biodefense medical countermeasures for smallpox. Reauthorization of the Pandemic and All-Hazards Preparedness Act (H.R. 2405 and S. 1855). FY2013 HHS/BARDA funding (Senate Labor-HHS Appropriations and House Labor-HHS Appropriations). Biomedical Advanced Research and Development Authority (BARDA)

Medicare payment for Part B drugs and biologics.

Regulation of radiolabeled medical products. Drug shortages for oncology products.

Issues Related to FDA regulation of needle-free jet administration of vaccines.

Legislative and regulatory matters related to the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) with a focus on the regulation of novel therapeutics for the treatment of obesity.

Medicare drug reimbursement.

S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

Issues related to Dextromethorphan; issues related to Pseudoephedrine; issues related to the regulation of Cosmetic Productions; HR 2359, "Safe Cosmetics Act of 2011," regarding all provisions.

Implementation of Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152)

S.3187, Food and Drug Administration Safety and Innovation Act.

H.R. 3497, the MODDERN Cures Act.

S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)

Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairness for Amputees Act (S. 773).

Colorectal Cancer Medicare and Reimbursement Issues; H.R. 3198 Supporting Colorectal Examination and Education Now Act of 2011; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152).

Medicare Reimbursement regarding SGR and ASC payments.

S.3187, Food and Drug Administration Safety and Innovation Act; Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011

S.510 FDA Food Safety Modernization Act; H.R. 2749 Food Safety Enhancement Act of 2009; S. 3307 Healthy, Hunger-Free Kids Act of 2010; H.R. 5504 Improving Nutrition for America's Children Act.

Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)

Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of 2011(P.L. 112-25) (Part B payment for drugs and biologics)

Medicare Part D; Medicare coverage policy for chronic renal disease; Medicare Part B reimbursement and coverage of dialysis products; Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25)

Implementation of P.L. 111-148, Patient Protection and Affordable Care Act and Implementation of P.L. 111-152, Health Care and Education Reconciliation Act (Biosimilars); (Independent Payment Advisory Board "IPAB"); Reauthorization of the Prescription Drug User Fee Act; Budget Control Act of 2011 (P.L. 112-25)